Benefits of BPC LPT

  • Chewable form with enhanced absorption

Why BPC LPT?

  • Patent pending
  • Improved absorption
  • BPC LPT is a highly advanced technology in a convenient, solid, chewable dosage form.
  • LPT particles don’t clump like liquid liposomes
  • Greater Bioavailability
  • Room temperature stable- no refrigeration necessary
  • The smaller the particle size, the greater bioavailability

Suggested dosage- Take one-half tablet one to two times daily. 60 tablets in each bottle  

For sensitive patients: Take half a tablet every other day in the morning, working up to a whole tablet every other day.

This product is gluten free.

*Joo SS et al.Prevention of inflammation-mediated neurotoxicity by Rg3 and its role in microglial activation. Biol Pharm Bull. 2008 Jul;31(7):1392-6.
*Bao HY, Zhang J, Yeo SJ, et al. Memory enhancing and neuroprotective effects of selected ginsenosides. Arch Pharm Res. 2005 Mar;28(3):335-42.
*Lee H, et al. Relationship between ginsenoside Rg3 and metabolic syndrome. Front Pharmacol. 2020;11:130.

BPC 157 LPT Tablets 60tabs

 

Benefits of BPC LPT

  • Chewable form with enhanced absorption

Why BPC LPT?

  • Patent pending
  • Improved absorption
  • BPC LPT is a highly advanced technology in a convenient, solid, chewable dosage form.
  • LPT particles don’t clump like liquid liposomes
  • Greater Bioavailability
  • Room temperature stable- no refrigeration necessary
  • The smaller the particle size, the greater bioavailability

Suggested dosage- Take one-half tablet one to two times daily. 60 tablets in each bottle  

For sensitive patients: Take half a tablet every other day in the morning, working up to a whole tablet every other day.

This product is gluten free.

*Joo SS et al.Prevention of inflammation-mediated neurotoxicity by Rg3 and its role in microglial activation. Biol Pharm Bull. 2008 Jul;31(7):1392-6.
*Bao HY, Zhang J, Yeo SJ, et al. Memory enhancing and neuroprotective effects of selected ginsenosides. Arch Pharm Res. 2005 Mar;28(3):335-42.
*Lee H, et al. Relationship between ginsenoside Rg3 and metabolic syndrome. Front Pharmacol. 2020;11:130.